The GNAZ Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population engineered to disrupt the GNAZ gene in the HeLa human cervical adenocarcinoma cell line. This polyclonal pool provides a heterogeneous loss-of-function model for studying GNAZ-mediated signaling without the constraints of single-cell clonal selection, enabling robust population-level analyses. The genetic disruption abolishes functional expression of the G protein subunit alpha z (G??z), allowing dissection of its role in inhibitory G protein-coupled receptor (GPCR) pathways.
The HeLa host cell line is an immortalized epithelial line originally derived from a cervical adenocarcinoma. HeLa cells are extensively characterized and widely employed in biomedical research, including cancer biology, signal transduction, and drug discovery. Their rapid proliferation, ease of genetic manipulation, and well-documented GPCR expression profile make them an ideal chassis for interrogating G protein signaling. The GNAZ knockout HeLa polyclonal cells thus leverage this robust cellular background to facilitate functional studies of G??z.
GNAZ encodes G??z, a member of the inhibitory Gi/o class of G protein alpha subunits. Upon GPCR activation by ligands such as chemokines, catecholamines, opioids, or dopamine, G??z dissociates from G?¦? and inhibits adenylate cyclase, leading to reduced cAMP levels and diminished protein kinase A (PKA) activity. Concurrently, the released G?¦? subunits activate downstream effectors including PI3K/Akt and MAPK/ERK cascades, while also recruiting G protein-coupled receptor kinases (GRKs) that promote receptor desensitization. G??z activity is modulated by regulator of G protein signaling (RGS) proteins and is known to interact with specific adenylate cyclase isoforms, ion channels, and receptor kinases, integrating diverse signals that influence cell proliferation, survival, and migration.
In HeLa cells, G??z exerts context-dependent effects on key cancer-related pathways. Dysregulation of GPCR signaling, including through GNAZ, has been implicated in oncogenesis, thrombosis, and neurological disorders. Loss of G??z function may alter basal cAMP levels and perturb the balance of PI3K/Akt and MAPK/ERK signaling, pathways frequently hijacked in cervical and other adenocarcinomas. This knockout model therefore provides a valuable tool to investigate how G??z contributes to HeLa cell proliferation, adhesion, and response to extracellular cues, potentially revealing vulnerabilities exploitable in targeted cancer therapies.
The GNAZ Knockout HeLa Polyclonal Cells are suitable for a wide range of experimental applications, including GPCR signaling studies using cAMP accumulation assays, western blotting for phospho-ERK and phospho-Akt, and RT-qPCR analysis of downstream target genes. They enable drug screening for GPCR ligands with selectivity for G??z-coupled receptors and can be used in co-immunoprecipitation experiments to map G protein?Ceffector interactions. Calcium flux assays and cell proliferation studies further extend their utility in functional genomics and pharmacological profiling. For further inquiries or to acquire this product, please contact Ascent Research.
